Brief: Arca Biopharma Announces First Quarter 2021 Financial Results

Oruka Therapeutics

11/05/2021 22:01

May 11 (Reuters) - ARCA Biopharma Inc  ABIO.O :
    * ARCA BIOPHARMA ANNOUNCES FIRST QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * Q1 LOSS PER SHARE $0.33
    * TOPLINE DATA FROM PHASE 2B CLINICAL TRIAL EVALUATING
RNAPC2 AS A
POTENTIAL TREATMENT FOR COVID-19 ANTICIPATED IN Q3 OF 2021
    * BELIEVES THAT ITS CURRENT CASH AND CASH EQUIVALENTS WILL
BE
SUFFICIENT TO FUND ITS OPERATIONS THROUGH 2022
    * CASH AND CASH EQUIVALENTS WERE $66.9 MILLION AS OF MARCH
31,
2021, COMPARED TO $49.1 MILLION AS OF DECEMBER 31, 2020

Source text for Eikon:  ID:nGNX5sl5Pr 
Further company coverage:  ABIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))